Annals of Surgical Oncology 1/2016 | springermedizin.de
Ioannis D. Kyriazanos - Clinical Oncology Journal (ISSN 2766-9882)
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Short-term outcomes of patients undergoing HPB procedures as part of... | Download Scientific Diagram
hipec - YouTube
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Konstantinos Votanopoulos, MD, PhD, FACS | Atrium Health Wake Forest Baptist
Survival results in 49 patients after HIPEC (hyperthermic... | Download Scientific Diagram
Current Issue Table of Contents: European Journal of Surgical Oncology
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Surgical Oncology | Rutgers Cancer Institute of New Jersey
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
hipec - YouTube
Significance of Urinary Tract Involvement in Patients Treated with Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy ( HIPEC) | Semantic Scholar
Operating personnel safety during the administration of Hyperthermic Intraperitoneal Chemotherapy (HIPEC). | Semantic Scholar
PDF) Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience
Complications after CRS and HIPEC | Download Table
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older Than 70 Years; Survival Benefit at Considerable Morbidity and Mortality | Semantic Scholar
Overall survival of 101 patients undergoing CRS/HIPEC for peritoneal... | Download Scientific Diagram
Onco Surgery - Σπηλιώτης Ιωάννης - Χειρουργός Ογκολόγος
John Spiliotis MD, PhD - Surgeon Oncologist, Director and Chairman Peritoneal Surface Oncology - Athens Medical Group & European Interbalkan Medical Center | LinkedIn
Σπηλιώτης Ιωάννης - Oncosurgery Spiliotis - YouTube
